Characteristics of Patent Ductus Arteriosus in Congenital Rubella Syndrome.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
19 11 2019
19 11 2019
Historique:
received:
15
11
2018
accepted:
14
10
2019
entrez:
21
11
2019
pubmed:
21
11
2019
medline:
13
11
2020
Statut:
epublish
Résumé
This study investigated the characteristics of congenital rubella syndrome (CRS)-associated cardiac complications, particularly patent ductus arteriosus (PDA). We reviewed the medical records of patients with CRS who were admitted to the Children's Hospital 1 in Vietnam between December 2010 and December 2012, and patients with CRS who underwent PDA transcatheter occlusion therapy at the cardiology department between December 2009 and December 2015. We compared the characteristics of PDA treated with transcatheter closure between children with CRS (CRS-PDA) and those without CRS (non-CRS-PDA) who underwent PDA transcatheter closure between July 2014 and December 2015. One-hundred-and-eight children with CRS were enrolled. Cardiac defects (99%), cataracts (72%), and hearing impairment (7%) were detected. Fifty CRS-PDA and 290 non-CRS-PDA patients were examined. CRS-PDA patients had smaller median birthweight (p < 0.001), more frequent pulmonary (p < 0.001) and aortic stenosis (p < 0.001), higher main pulmonary artery pressure, and higher aortic pressure in systole/diastole (p < 0.001 for each) than did non-CRS-PDA patients. The proportion of tubular-type PDA was higher in CRS-PDA patients (16%) than in non-CRS-PDA patients (3%) (p = 0.020). Tubular-type PDA was frequently seen in patients with CRS and accompanied by pulmonary/systemic hypertension and pulmonary/aortic stenosis; in these patients, more cautious device selection is needed for transcatheter PDA closure.
Identifiants
pubmed: 31745134
doi: 10.1038/s41598-019-52936-6
pii: 10.1038/s41598-019-52936-6
pmc: PMC6863812
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17105Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Références
Hypertens Res. 2013 May;36(5):440-3
pubmed: 23364342
J Autism Child Schizophr. 1971 Jan-Mar;1(1):33-47
pubmed: 5172438
Catheter Cardiovasc Interv. 2015 Aug;86(2):E66-72
pubmed: 26032159
Pediatr Int. 2015 Oct;57(5):820-7
pubmed: 26228894
Am J Cardiol. 1989 Apr 1;63(12):877-80
pubmed: 2929450
J Pediatr. 1980 Jan;96(1):88-93
pubmed: 7350322
Eur J Intern Med. 2013 Sep;24(6):562-7
pubmed: 23684500
Catheter Cardiovasc Interv. 2000 Sep;51(1):50-4
pubmed: 10973018
Vaccine. 2001 May 14;19(25-26):3311-9
pubmed: 11348695
Heart. 2002 Mar;87(3):260-3
pubmed: 11847167
Br Heart J. 1956 Oct;18(4):519-22
pubmed: 13374158
Birth Defects Res A Clin Mol Teratol. 2010 Jan;88(1):1-8
pubmed: 19697432
J Pediatr. 1978 Jul;93(1):62-6
pubmed: 650346
Eur J Echocardiogr. 2009 Jan;10(1):1-25
pubmed: 19065003
Catheter Cardiovasc Interv. 2013 Aug 1;82(2):245-52
pubmed: 23460349
Circulation. 2006 Oct 24;114(17):1873-82
pubmed: 17060397
Circulation. 2008 Dec 2;118(23):e714-833
pubmed: 18997169
Vaccine. 2014 Feb 26;32(10):1192-8
pubmed: 24021315
Circulation. 1967 Oct;36(4):544-54
pubmed: 6041868
Circulation. 2013 Dec 3;128(23):2542-5
pubmed: 24297819
Sci Rep. 2017 Apr 13;7:46483
pubmed: 28406248
Vaccine. 2015 Jul 17;33(31):3673-7
pubmed: 26087296
Arch Ophthalmol. 2004 Apr;122(4):541-5
pubmed: 15078672
Pediatrics. 2014 Aug;134(2):e519-26
pubmed: 25002666
Heart. 2016 May;102 Suppl 2:ii14-22
pubmed: 27053693
Can Med Assoc J. 1967 Nov 25;97(22):1329-34
pubmed: 6061597
J Pediatr. 1967 Jul;71(1):59-65
pubmed: 5293860
Postepy Kardiol Interwencyjnej. 2013;9(1):93-6
pubmed: 24570696
Br J Ophthalmol. 1993 Jun;77(6):358-63
pubmed: 8318483
Pediatr Pulmonol. 2004 Jul;38(1):2-22
pubmed: 15170869
Eur Heart J Cardiovasc Imaging. 2017 Mar 1;18(3):254-275
pubmed: 28363204